[144] Barrett Business Services SEC Filing
Rhea-AI Filing Summary
Barrett Business Services' Form 144 reports a proposed sale of 12,646 shares of common stock to be executed through Morgan Stanley Smith Barney, with an aggregate market value of $602,179.76. The filing lists total shares outstanding as 25,689,563 and an approximate sale date of 08/13/2025.
The record shows the 12,646 shares were acquired on 08/13/2025 by exercise of options under a registered plan (10,000 and 2,646 shares) and are characterized as compensation. The notice also discloses prior sales on 05/20/2025 totaling 12,354 shares for gross proceeds of $527,267.86. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale notice for 12,646 shares following option exercise; size is immaterial relative to outstanding shares.
The filing documents a proposed disposition of 12,646 common shares with an aggregate value of $602,179.76. Using the reported outstanding share count of 25,689,563, the transaction represents roughly 0.05% of outstanding stock, indicating limited immediate dilution or market impact. The shares were acquired the same day by exercising options under a registered plan and are listed as compensation, which is common for insiders monetizing option exercises. Recent disclosed sales on 05/20/2025 total 12,354 shares for $527,267.86, showing prior monetizations in the same period. Overall, this is a disclosure of insider selling activity rather than a company operational development.
TL;DR: Form 144 disclosure follows required Rule 144 procedure and includes customary representations; no governance red flags are apparent from this notice alone.
The form identifies the broker channel and documents acquisitions via option exercise and subsequent proposed sales, consistent with Rule 144 reporting obligations. The notice includes the standard attestation about knowledge of material adverse information and references the Rule 10b5-1 framework for trading plans, although no plan adoption date is shown. Prior sales in May 2025 are disclosed, demonstrating recurring insider liquidity events. There is no explicit indication of irregular governance issues or undisclosed related-party transactions within the provided content.